We are live on ! Find out more
TECH icon

Bio-Techne

292 hedge funds and large institutions have $4.46B invested in Bio-Techne in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 105 increasing their positions, 102 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 17

4% more funds holding

Funds holding: 280292 (+12)

3% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 102

2% more capital invested

Capital invested by funds: $4.39B → $4.46B (+$68.8M)

4% less call options, than puts

Call options by funds: $931K | Put options by funds: $967K

5.7% less ownership

Funds ownership: 400.56%394.86% (-5.7%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
292
Holders Change
+12
Holders Change %
+4.29%
% of All Funds
7.28%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
34
Increased
105
Reduced
102
Closed
17
Calls
$931K
Puts
$967K
Net Calls
-$36K
Net Calls Change
-$1.19M

TECH Hedge Fund Activity: Q3 2017 in Review

292 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2017, worth a combined $4.46B — up 1.6% from $4.39B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new TECH positions and 17 closed out — a net gain of 17 holders — while 105 added to existing stakes and 102 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $18M. The largest seller was Select Equity Group, cutting an estimated $36.6M.

  • 292 institutional investors held Bio-Techne (TECH) as of Q3 2017, up from 280 in Q2 2017.
  • Funds reported $4.46B of Bio-Techne stock for Q3 2017, up 1.6% quarter-over-quarter.
  • 34 funds opened new Bio-Techne positions in Q3 2017 and 17 closed out, a net change of +17 holders.
  • The largest Bio-Techne buyer in Q3 2017 was Millennium Management, an estimated $18M added.
  • The largest Bio-Techne seller in Q3 2017 was Select Equity Group, an estimated $36.6M sold.

Based on aggregated 13F filings for Q3 2017.